Millipore Sigma Vibrant Logo

AGX840 Recombinant SARS-CoV-2 Nucleocapsid Protein（whole length）

This e. coli recombinant SARS-CoV-2 Nucleocapsid Protein（whole length）, Cat. No. AGX840 is tested for use in ELISA.

View This Product on Sigma-Aldrich
AGX840
1 mg  
価格を検索中…
価格が見つかりません
Minimum Quantity needs to be mulitiple of
Maximum Quantity is
弊社照会 詳細を表示　
値引
()
 
—
弊社照会
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

       

      お問合せください

      概要

      Replacement Information
      Description
      Catalogue NumberAGX840
      DescriptionRecombinant SARS-CoV-2 Nucleocapsid Protein（whole length）
      Alternate Names
      • SARS-CoV
      • 2019-nCoV
      Background InformationCoronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleocapsid antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).
      References
      Product Information
      FormatPurified
      PresentationPurified recombinant protein in 0.01M PBS, pH7.4
      Quality LevelMQ100
      Applications
      ApplicationThis e. coli recombinant SARS-CoV-2 Nucleocapsid Protein（whole length）, Cat. No. AGX840 is tested for use in ELISA.
      Key Applications
      • ELISA
      Biological Information
      CloneN/A
      ConcentrationPlease refer to guidance on suggested starting dilutions and/or titers per application and sample type.
      HostE. coli
      SpecificitySARS CoV2
      Purification Methodni-sepharose
      UniProt Number
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles.
      Packaging Information
      Material Size1 mg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      AGX840 04061842443536

      Documentation

      Recombinant SARS-CoV-2 Nucleocapsid Protein（whole length） (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      Recombinant SARS-CoV-2 Nucleocapsid Protein（whole length） 試験成績書（CoA）

      タイトルロット番号
      Recombinant SARS-CoV-2 Nucleocapsid Protein (whole length) - 3614140 3614140
      Recombinant SARS-CoV-2 Nucleocapsid Protein (whole length) - 3688998 3688998
      Recombinant SARS-CoV-2 Nucleocapsid Protein (whole length) - 3821521 3821521
      Recombinant SARS-CoV-2 Nucleocapsid Protein (whole length) - 3906480 3906480
      Recombinant SARS-CoV-2 Nucleocapsid Protein (whole length) - 3909642 3909642
      Recombinant SARS-CoV-2 Nucleocapsid Protein (whole length) - 3911795 3911795
      Recombinant SARS-CoV-2 Nucleocapsid Protein (whole length) - 3943833 3943833
      Recombinant SARS-CoV-2 Nucleocapsid Protein (whole length) - 3974623 3974623
      Recombinant SARS-CoV-2 Nucleocapsid Protein (whole length) - 3987287 3987287
      Recombinant SARS-CoV-2 Nucleocapsid Protein (whole length) - 4043802 4043802
      Show more